APA (7th ed.) Citation

Hamamoto, R., Koyama, T., Kouno, N., Yasuda, T., Yui, S., Sudo, K., . . . Yamamoto, N. (2022). Introducing AI to the molecular tumor board: One direction toward the establishment of precision medicine using large-scale cancer clinical and biological information. Experimental Hematology & Oncology, 11(1), 1. https://doi.org/10.1186/s40164-022-00333-7

Chicago Style (17th ed.) Citation

Hamamoto, Ryuji, et al. "Introducing AI to the Molecular Tumor Board: One Direction Toward the Establishment of Precision Medicine Using Large-scale Cancer Clinical and Biological Information." Experimental Hematology & Oncology 11, no. 1 (2022): 1. https://doi.org/10.1186/s40164-022-00333-7.

MLA (9th ed.) Citation

Hamamoto, Ryuji, et al. "Introducing AI to the Molecular Tumor Board: One Direction Toward the Establishment of Precision Medicine Using Large-scale Cancer Clinical and Biological Information." Experimental Hematology & Oncology, vol. 11, no. 1, 2022, p. 1, https://doi.org/10.1186/s40164-022-00333-7.